About Us
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|
|
|
MYGN - Myriad Genetics| Previous Close | $27.84 | Open | $27.95 |
| Volume | 405.7K | Market Cap | 1.785B |
| Yield | Last Dividend |
| Cancer Biomarkers Market US$ 31,206.00 M... | 03/02/21 |
| Cancer Biomarkers Market research report delivers a comprehensive study on production capacity, consumption, import and export for all major regions a... | |
| The Daily Biotech Pulse: Adcom Test Awai... | 02/26/21 |
| Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Feb. 25) Apy... | |
| Cancer Biomarkers Market to Set Phenomen... | 02/23/21 |
| Global Cancer Biomarkers Market Report 2021 is latest research study released by HTF MI evaluating the market, highlighting opportunities, risk side a... | |
| Myriad Genetics Analysts Are Pretty Bull... | 02/22/21 |
| Myriad Genetics announce their quarterly, annual earnings. See the latest EPS estimates. Listen to the conference call and remind yourself by??? | |
| The Week Ahead In Biotech: J&J Vaccine A... | 02/20/21 |
| Biotech stocks pulled back along with the broader market in the holiday-shortened week ended Feb 19. Earnings news flow was light before picking up pa... | |
| PARP Inhibitor Biomarkers Market Covid19... | 02/08/21 |
| Coherent Market Insights announced that it???s published an exclusive report namely Global PARP Inhibitor Biomarkers Market by Manufacturers, Regions,... | |
| The Daily Biotech Pulse: Novartis COVID-... | 02/04/21 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Feb. 3) 9 Me... | |
| Myriad Genetics Launches New Vectra?? Ca... | 02/02/21 |
| Sample test report for Vectra CV. Sample test report for Vectra CV. SALT LAKE CITY, Feb. 02, 2021 (GLOBE NEWSWIRE) -- To help more patients with rheum... | |
| Liquid Biopsy Market Size, Outlook, Oppo... | 01/15/21 |
| Global Liquid Biopsy Market research report provides an in-depth analysis of the industry and economy-wide database for the business management that c... | |
| Illumina Announces New and Expanded Onco... | 01/11/21 |
| SAN DIEGO--(BUSINESS WIRE)--With genetic sequencing at the forefront of precision medicine, Illumina (NASDAQ: ILMN) is pleased to announce a portfolio... | |
| Global Genomic Biomarkers Market Trends,... | 01/07/21 |
| This Genomic Biomarkers concerning the Genomic Biomarkers market has been published to assist the user in understanding the market as a whole, its def... | |
| Myriad Genetics Up on Strategic-Options ... | 01/06/21 |
| Myriad Genetics stock traded higher after the diagnostic-testing company said it was pursuing strategic alternatives for its Vectra autoimmune busines... | |
| Stocks making the biggest moves after th... | 01/05/21 |
| These are the stocks posting the largest moves after hours on Tuesday. | |
| Global Genetic Testing Market Outlook to... | 12/16/20 |
| DUBLIN, Dec. 16, 2020 /PRNewswire/ -- The "Global Genetic Testing Market Outlook 2022" report has been added to ResearchAndMarkets.com's offering. "Gl... | |
| Dec 15, 2020 ??? Glenview Capital Admini... | 12/16/20 |
| Dec 15, 2020 - Glenview Capital Administration Buys Myriad Genetics Inc, Medtronic PLC, Amgen Inc, Sells Nuance Communications Inc, ViacomCBS Inc, HCA... | |
| Genetic Testing Market 2020 Global Exclu... | 12/15/20 |
| Market Synopsis of Global Genetic testing Market: Genetic Testing Market is expected to grow at CAGR of 11.50% to reach USD 22834.19 million till 2024... | |
| Global Clinical Oncology Next Generation... | 12/10/20 |
| ???Global Clinical Oncology Next Generation Sequencing Market- Industry Trends and Forecast to 2027??? Worldwide Industry Size, Offer and trends analy... | |
| Preventive Healthcare Technologies And S... | 12/09/20 |
| The Preventive Healthcare Technologies And Services Market (2020) research report explores the market in terms of Revenue And Emerging Market Trends a... | |
| Companion Diagnostics Market Impact Of c... | 12/02/20 |
| An informative study on the Companion Diagnostics Market from 2020-2027 has lately released for the database of Coherent Market Insights that helps by... | |
| PARP Inhibitor Biomarkers Market - Myria... | 11/24/20 |
| An informative study on the PARP Inhibitor Biomarkers Market from 2020-2027 has lately released for the database of Coherent Market Insights that help... | |
| Consumer Genomics Market : COVID-19 Impa... | 11/17/20 |
| Analysis and discussion of important industry trends, market size, and market share estimates are revealed in the Consumer Genomics Market research re... | |
| Direct-to-consumer Genetic Testing Marke... | 11/16/20 |
| The Direct-to-consumer Genetic Testing market report gives an in-depth analysis of the global market where it includes drivers, restraints, and trends... | |
| Myriad Genetics Announces Global Expansi... | 11/16/20 |
| SALT LAKE CITY, Nov. 16, 2020 (GLOBE NEWSWIRE) ??? Myriad Genetics, Inc. (NASDAQ: MYGN), a global leader in molecular diagnostics and precision medici... | |
| Myriad Genetics Earnings and Growth Anal... | 11/09/20 |
| Myriad Genetics announce their quarterly, annual earnings. See the latest EPS estimates. Listen to the conference call and remind yourself by??? | |
| Myriad Genetics Q1 2021 Earnings Preview... | 11/08/20 |
| Myriad Genetics (NASDAQ:MYGN) is scheduled to announce Q1 earnings results on Monday, November 9th, after market close. The consensus EPS Estimate is ... | |
| Liquid Biopsy Market (COVID-19 Impact An... | 10/27/20 |
| This Liquid Biopsy Market research report makes available state-of-the-art information about the entire market along with the holistic view of the mar... | |
| Myriad Genetics (NASDAQ:MYGN) Stock Pric... | 10/23/20 |
| Shares of Myriad Genetics, Inc. (NASDAQ:MYGN) rose 5.1% on Wednesday . The company traded as high as $14.07 and last traded at $14.02. Approximately 6... | |
| Financial Analysis: Myriad Genetics (NAS... | 10/22/20 |
| Myriad Genetics (NASDAQ:MYGN) and Navidea Biopharmaceuticals (NYSE:NAVB) are both small-cap medical companies, but which is the superior business? We ... | |
| Myriad Genetics (NASDAQ:MYGN) Trading 5.... | 10/21/20 |
| Shares of Myriad Genetics, Inc. (NASDAQ:MYGN) traded up 5.1% during mid-day trading on Wednesday . The company traded as high as $14.07 and last trade... | |
| Myriad Genetics (NASDAQ:MYGN) Cut to Sel... | 10/19/20 |
| BidaskClub lowered shares of Myriad Genetics (NASDAQ:MYGN) from a hold rating to a sell rating in a research note released on Friday morning, BidAskCl... | |
| Buy rating | 02/24/21 |
| SVB Leerink maintains Market Perform rating and raises Price Target from $20.00 to $33.00 | |
| Date | 2021-02-23 (AMC) | Est. (EPS/Rev.) | ($0.12)/ 150.39M |
| Actual (EPS/Rev.) | $-0.12/ $154.60 M | EPS (TTM) | 0 |
| Total Revenue | $1.3B | Total Liabilities | $2.1B |
| Cost of Revenue | $2.5B | Total cash flow | $3.2 |
| Total Assets | $29.98B |
| % Insider | 12.52% | % Institutional | 76.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Service Name | Trader | % Success | |
|---|---|---|---|
| Big Data Zhou | Zhou Academy | 82.00 % | Subscribe |
| Symmetry Options | Symmetry Options | 33.00 % | Follow |
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.
